143 related articles for article (PubMed ID: 7686128)
21. Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C.
Brillanti S; Masci C; Ricci P; Miglioli M; Barbara L
Hepatology; 1992 Jun; 15(6):998-1001. PubMed ID: 1317344
[TBL] [Abstract][Full Text] [Related]
22. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
Brown D; Powell L; Morris A; Rassam S; Sherlock S; McIntyre N; Zuckerman AJ; Dusheiko GM
J Med Virol; 1992 Nov; 38(3):167-71. PubMed ID: 1283751
[TBL] [Abstract][Full Text] [Related]
23. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.
Shindo M; Di Bisceglie AM; Cheung L; Shih JW; Cristiano K; Feinstone SM; Hoofnagle JH
Ann Intern Med; 1991 Nov; 115(9):700-4. PubMed ID: 1656828
[TBL] [Abstract][Full Text] [Related]
24. [Long-term treatment of cryptogenic hepatitis C using recombinant interferon alpha].
Hopf U; Möller B; König V; Küther S; Lobeck H; Huhn D
Z Gastroenterol; 1990 Sep; 28(9):453-7. PubMed ID: 2125776
[TBL] [Abstract][Full Text] [Related]
25. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
[TBL] [Abstract][Full Text] [Related]
26. [Prevalence and significance of the C virus antibody in chronic hepatopathy not related to B virus in alcoholics].
Bárcena Marugán R; Herrero C; Fernández R; Avilés J; Pascasio JM; Aguilera D; Erdozaín JC; Gil Grande L; Boixeda D; Martín de Argila C
Rev Esp Enferm Dig; 1992 Feb; 81(2):112-6. PubMed ID: 1314633
[TBL] [Abstract][Full Text] [Related]
27. [IgM HCV antibody in chronic hepatitis and liver cirrhosis].
Shibuya A; Sakurai K; Takeuchi A; Shibata H
Rinsho Byori; 1992 Jul; 40(7):757-60. PubMed ID: 1380570
[TBL] [Abstract][Full Text] [Related]
28. Different types of chronic hepatitis in alcoholic patients: does chronic hepatitis induced by alcohol exist?
Takase S; Takada N; Enomoto N; Yasuhara M; Takada A
Hepatology; 1991 May; 13(5):876-81. PubMed ID: 1903124
[TBL] [Abstract][Full Text] [Related]
29. Anti-C100-3 antibody status, viral genomic sequences, and clinical features in chronic hepatitic patients with hepatitis C virus RNA in sera.
Morii K; Shimomura H; Nakagawa H; Hasui T; Tsuji T
Acta Med Okayama; 1992 Aug; 46(4):285-93. PubMed ID: 1332424
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus infection in medical personnel after needlestick accident.
Mitsui T; Iwano K; Masuko K; Yamazaki C; Okamoto H; Tsuda F; Tanaka T; Mishiro S
Hepatology; 1992 Nov; 16(5):1109-14. PubMed ID: 1427651
[TBL] [Abstract][Full Text] [Related]
31. [Hepatitis C virus antibodies in chronic non-alcoholic liver disease].
Silva H; Muñoz G; Sánchez G; Jirón MI; Wolff C; Varas A; Giaconi X; Vargas C; Soto JR; Armas R
Rev Med Chil; 1993 Feb; 121(2):148-51. PubMed ID: 7508139
[TBL] [Abstract][Full Text] [Related]
32. Detection of antibody to hepatitis C E2/NS1 protein in patients with type C hepatitis.
Yokosuka O; Ito Y; Imazeki F; Ohto M; Omata M
Biochem Biophys Res Commun; 1992 Nov; 189(1):565-71. PubMed ID: 1280430
[TBL] [Abstract][Full Text] [Related]
33. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
Nagayama R; Miyake K; Tsuda F; Okamoto H
J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity of an anti-HCV core peptide ELISA.
Bresters D; Reesink HW; Cuypers HT; Jansen PL; Mauser-Bunschoten EP; van der Poel CL; Lelie PN
J Med Virol; 1992 Jul; 37(3):187-91. PubMed ID: 1279109
[TBL] [Abstract][Full Text] [Related]
35. [The hepatitis C virus--principal causative agent in non-A, non-B hepatitis].
Schaff Z; Lapis K
Orv Hetil; 1990 Sep; 131(35):1903-6. PubMed ID: 2170894
[TBL] [Abstract][Full Text] [Related]
36. Expression of the amino-terminal half of the NS1 region of the hepatitis C virus genome and detection of an antibody to the expressed protein in patients with liver diseases.
Inoue Y; Suzuki R; Matsuura Y; Harada S; Chiba J; Watanabe Y; Saito I; Miyamura T
J Gen Virol; 1992 Aug; 73 ( Pt 8)():2151-4. PubMed ID: 1379627
[TBL] [Abstract][Full Text] [Related]
37. [Factors influencing the effect of ursodeoxycholic acid therapy in chronic hypertransaminasemia].
Buongiorno G; Quaranta GM; Guerra V; Misciagna G; Manghisi OG
Recenti Prog Med; 1992 May; 83(5):298-302. PubMed ID: 1439111
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
Saracco G; Abate ML; Baldi M; Calvo PL; Manzini P; Brunetto MR; Oliveri F; Kuo G; Chien D; Houghton M
Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of anti-hepatitis C virus antibodies in patients with acute nonA nonB hepatitis and different outcome of liver disease.
Giuberti T; Ferrari C; Marchelli S; Degli Antoni AM; Schianchi C; Pizzaferri P; Fiaccadori F
Liver; 1992 Apr; 12(2):94-9. PubMed ID: 1320178
[TBL] [Abstract][Full Text] [Related]
40. [Non-A, Non-B hepatitis: advances in diagnosis and therapy].
Bühler H
Schweiz Med Wochenschr; 1991 May; 121(20):721-6. PubMed ID: 1647547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
